On March 2, 2026, in Mississauga, Ontario, BioSyent Inc. completed the acquisition of Oral Science Inc., a private Canadian distributor from Brossard, Quebec. Oral Science specializes in healthcare products for dental hygiene and oral health. BioSyent, listed on TSX Venture as RX, successfully closed the acquisition deal, marking a significant milestone for the company. This acquisition allows BioSyent to expand its portfolio and reach in the healthcare sector, further solidifying its position in the market.